Sibel Guler

Prof. Sibel Guler

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2022 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
MZMaryam Zare
Maryam Zare
HÖHande Özdemir
Hande Özdemir
MTMerve Yalçın Tavşan
Merve Yalçın Tavşan
FTFiliz Tuna
Filiz Tuna
NSNecdet Süt
Necdet Süt
DKDerya Demirbağ Kabayel
Derya Demirbağ Kabayel


1 August 2014 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
SGSibel Guler
Sibel Guler
UUUfuk Utku
Ufuk Utku
ÖAÖzer Aynaci
Özer Aynaci

1 January 2015 in Ideggyogyaszati Szemle
Verified
Journal Article
Closed access
SGSibel Guler
Sibel Guler
YKYüce Dogru Özlem Sarı Kaplan
Yüce Dogru Özlem Sarı Kaplan
ATAslan Tekatas
Aslan Tekatas
ÖAÖzer Arican
Özer Arican
ÖKÖzlem Sarı Kaplan
Özlem Sarı Kaplan
YDYüce Dogru
Yüce Dogru
Értékeltük a nyugtalan láb szindróma (RLS) prevalenciáját és súlyosságát psoriasisos betegek esetében, és vizsgáltuk annak hatását az alvásra és az életminőségre.

30 May 2019 in Neurological Research
Verified
Journal Article
Closed access
SGSibel Guler
Sibel Guler
ACAyşe Caylan
Ayşe Caylan
FTF.Nesrin Turan
F.Nesrin Turan
NDNezih Dağdeviren
Nezih Dağdeviren
Objective: We aimed to determine the prevalence and risk factors of Essential Tremor (ET) in Edirne and its districts, located in Western Thrace, which is the most western part of Turkey. Methods: In this study, 3008 individuals who could communicate and agreed to participate in the study were evaluated. To obtain the data from the applicants in 30 Family Health Centres in Edirne and its districts, a face-to-face questionnaire that consisted of 37 questions was prepared by the researchers. The questionnaire included general information, questions to evaluate potential concomitant comorbid conditions and questions regarding the symptomatology used in ET diagnosis, as well as questions to evaluate ET severity, was examined with the spiral test. Patients were classified by using the Washington Heights-Inwood Genetic Study of Essential Tremor (WHIGET) diagnostic and clinical evaluation scale. According to the diagnostic criteria for ET (used in participants who were examined and in those whose medical records were reviewed) were similar to those used in astudy conducted in Turkey. Results: Of 3008 individuals, 173 were diagnosed with ET according to the questionnaire results from Edirne and its districts, and the prevalence of ET was 5.8%. Approximately, 43.4% of the patients with ET were male, and 56.6% were female, which was not significantly different (p > 0.05). Participants with tremor related to alcohol withdrawal, hyperthyroidism, anxiety, depression other known causes of tremor were not considered to have ET. Thyroid disease was identified in 0.0% of the cases, and the control group was detected in 1.4%, which was not significantly different (p = 0.170). Psychiatric disease was identified in 0.0% of the cases, and the control group was detected in 1.3%, which was not significantly different (p = 0.271). Conclusions: ET prevalence studies will increase the awareness of the community and provide early diagnosis and treatment, as well as serve as a basis to reduce morbidity and improve the quality of life.

5 August 2012 in ISRN Neurology
Verified
Journal Article
Open access
PDF file
SGSibel Guler
Sibel Guler
LBLevent Sinan Bir
Levent Sinan Bir
BABeyza Akdag
Beyza Akdag
FAFusun Ardıc
Fusun Ardıc
The aim of this study was to determine balance problems and severity and ratio of postural instability of newly diagnosed, early stage Parkinson’s patients who did not receive any antiparkinson treatment before, to evaluate fall risk clinically and posturographically and to examine the effects of pramipexole on these signs and symptoms. Detailed posturographic assessments which involved central vestibular, visual, peripheric vestibular somatosensory field tests were applied to both patient and control subjects and fall risk was determined. There was not statistically significant difference between patients and control subjects before and after drug therapy in the assesment of fall risk in posturography and there was not any improvement with drug usage in the patient group. However, in the analysis of subsystems separately, only the involvement in central vestibular field was more severe and could appear at all positions in Parkinson’s patients comparing with the control group, and pramipexole was partially effective in improving this disorder. Central vestibular field is the subsystem that should be examined with first priority. Posturography is relatively reliable in defining fall risk and postural instability ratio in Parkinson’s disease. But it should be considered that clinical assessment tools can be more sensitive in the evaluation of balance and postural disorders and in the follow-up of the response to drug therapy.